Manufacturer record

Taj Pharma India Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Taj Pharma India Ltd (Gujarat) were declared Not of Standard Quality between May 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Taj Pharma India Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2026 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2026
4
Products affected
Assay
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2026 · 4

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Orlistat Capsules USP 120 mg TPC25015Mfg 2025-09 · Exp 2027-08 01.IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay SFDTL UttarakhandState lab Jul 2026
Obelow-60 (Orlistat Capsules USP 60 mg TPC26003Mfg 2026-01 · Exp 2027-12 01. IDENTIFICATION TEST OF ORLISTAT U.S.P. ? Found to be negative. 02. ASSAY OF ORLISTAT U.S.P.: NIL.Assay SFDTL UttarakhandState lab Jul 2026
Voglibose, Glimepiride & Metformin HCl (SR) Tablets). TPT26010Mfg 2026-01 · Exp 2027-12 Description : one out of 20 tablets blue layer half broken found. & Assay of Glimepiride IP- less than Prescribed limitAssay SDTL, UttarakhandState lab May 2026
Metformin HCl I.P. (as Prolonged Release Form & Glimepiride I.P TPT26008Mfg 2026-01 · Exp 2027-12 Assay of Glimepiride IP- less than Prescribed limitAssay SDTL, UttarakhandState lab May 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.